Avalon Globocare Corp (ALBT) Financials
Newest figures come from the S-1 for Q1 FY2026, filed Jul 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALBT SEC filings page.
This page shows Avalon Globocare Corp (ALBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Persistent operating cash consumption is financed externally while short-term liabilities dominate the balance sheet and reported assets include substantial goodwill.
Between FY2024 and FY2025, operating cash flow barely changed while net loss widened from-$7.9M to-$18.3M ; the divergence indicates that accounting earnings were increasingly affected by items that did not consume operating cash in the same proportion. Operating cash generation therefore remained more stable than reported earnings, but stayed negative.
FY2025 current liabilities were almost all total liabilities, and the current ratio was 0.1x; this is a near-term funding concentration, not simply a measure of total leverage. With goodwill exceeding half of total assets, the asset base also contains a large non-cash accounting component.
The business remained dependent on external financing: financing cash inflow was
Financial Health Signals
Avalon Globocare Corp does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Avalon Globocare Corp passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Avalon Globocare Corp reported a net loss of $18.3M while operations used $4.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Avalon Globocare Corp reported an operating loss of $7.6M against $1.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Avalon Globocare Corp's EBITDA was -$1.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.7% from the same quarter a year earlier.
Avalon Globocare Corp reported -$4.5M in net income in Q1 2026. This represents a decrease of 80.5% from the same quarter a year earlier.
Not reported for Q1 2026.
Cash & Balance Sheet
Avalon Globocare Corp held $776K in cash as of Q1 2026; long-term debt is not reported for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
Avalon Globocare Corp's ROE was -38.2% in Q1 2026, measuring profit generated per dollar of shareholder equity.
Not reported for Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Capital Allocation
None of these metrics is reported for Q1 2026.
ALBT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'26S-1 | Q4'25S-1 | Q3'25 | Q2'2510-Q | Q1'25 | Q4'24S-1 | Q3'24 | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | $350K+1.4% | $350K+6.9% | $350K-32.6% | $141K-68.5% | $345K-21.4% | $328K+6.8% |
| SG&A Expenses | $223K-27.7% | N/A | $230K-32.9% | $324K-9.3% | $309K-12.6% | $255K-35.2% | $343K-26.9% | $357K-21.3% |
| Operating Income | -$2.7M-52.4% | N/A | -$76K+94.0% | -$3.9M-158.4% | -$1.8M-111.8% | -$1.2M+87.5% | -$1.3M-11.3% | -$1.5M+27.3% |
| EBITDA | -$1.6M+4.7% | N/A | N/A | N/A | -$1.7M-165.0% | N/A | N/A | N/A |
| Interest Expense | $23K-95.9% | N/A | $267K-51.1% | $1.1M+30.9% | $560K+5185.2% | -$1.3M-102.5% | $547K+24.7% | $808K+228.0% |
| Net Income | -$4.5M-80.5% | N/A | -$254K+84.9% | -$13.5M-531.3% | -$2.5M-81.5% | -$2.7M+71.5% | -$1.7M-13.1% | -$2.1M+22.4% |
| EPS (Basic) | -$0.50+65.0% | N/A | -$0.06+96.7% | -$6.22-118.2% | -$1.43+23.1% | N/A | -$1.82+11.7% | -$2.85-955.6% |
| EPS (Diluted) | -$0.50 | N/A | -$0.06 | -$6.22 | -$1.43 | N/A | -$1.82 | -$2.85 |
| Diluted Shares (Avg) | 9M | N/A | 4M | 2M | 2M | N/A | 924,431 | 747,959 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Income Tax.
ALBT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'26S-1 | Q4'25S-1 | Q3'25 | Q2'2510-Q | Q1'25 | Q4'24S-1 | Q3'24 | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.2M+53.1% | $23.4M+11.5% | $9.1M-53.3% | $8.0M-59.1% | $10.6M-47.8% | $21.0M+2.0% | $19.6M-34.8% | $19.5M-35.4% |
| Current Assets | $1.7M-40.2% | $1.5M-53.8% | $2.1M+49.6% | $933K+30.9% | $2.8M+259.2% | $3.2M+280.4% | $1.4M+61.7% | $713K-49.9% |
| Cash & Equivalents | $776K-43.3% | $109K-95.9% | $334K-67.4% | $202K+0.5% | $1.4M+348.4% | $2.7M+831.4% | $1.0M+199.7% | $201K-69.3% |
| Inventory | $72K-20.3% | $75K-18.9% | $80K | $86K | $90K | $92K | N/A | N/A |
| Goodwill | $12.8M | $12.8M | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $4.5M-68.8% | $14.2M+2.1% | $13.6M-3.7% | $15.1M0.0% | $14.5M+1.6% | $13.9M+5.1% | $14.1M+7.6% | $15.1M+21.6% |
| Current Liabilities | $4.4M-69.2% | $14.1M+1.9% | $13.6M+10.3% | $15.1M+75.3% | $14.4M+85.2% | $13.9M+105.3% | $12.3M+84.3% | $8.6M+44.1% |
| Non-Current Liabilities | $77K+48.6% | $24K | $18K-99.0% | $35K-99.5% | $52K-99.2% | $0-100.0% | $1.8M-71.8% | $6.5M+0.8% |
| Total Equity | $11.7M+401.3% | $9.2M+30.0% | -$4.5M-183.2% | -$7.1M-261.0% | -$3.9M-164.3% | $7.1M-3.6% | $5.4M-67.9% | $4.4M-75.2% |
| Retained Earnings | -$110.4M-22.5% | -$105.9M-20.8% | -$103.9M-22.3% | -$103.6M-24.4% | -$90.2M-11.1% | -$87.7M-9.9% | -$84.9M-21.0% | -$83.3M-21.2% |
Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments, Long-Term Debt.
ALBT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'26S-1 | Q4'25S-1 | Q3'25 | Q2'2510-Q | Q1'25 | Q4'24S-1 | Q3'24 | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.9M-69.1% | -$192K+75.3% | -$1.4M+28.1% | -$1.3M-23.5% | -$1.7M-84.7% | -$777K+2.4% | -$1.9M-40.4% | -$1.1M+57.2% |
| Depreciation & Amortization | $1.1M+911.8% | N/A | N/A | N/A | $111K-47.3% | N/A | N/A | N/A |
| Stock-Based Compensation | $320K+1112.8% | N/A | N/A | N/A | $26K-42.4% | N/A | N/A | N/A |
| Investing Cash Flow | $281K+195.3% | $330K | $658K | $0 | $95K | $0-100.0% | $0-100.0% | N/A |
| Financing Cash Flow | $3.4M+1462.4% | $288K-90.1% | $835K-69.3% | $58K-94.6% | $220K-76.5% | $2.9M+296.7% | $2.7M+160.0% | $1.1M-53.2% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
ALBT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'26S-1 | Q4'25S-1 | Q3'25 | Q2'2510-Q | Q1'25 | Q4'24S-1 | Q3'24 | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | -21.8% | -1109.6% | -510.4% | -865.8% | -367.9% | -458.8% |
| Net Margin | N/A | N/A | -72.6% | -3840.9% | -709.6% | -1927.6% | -486.5% | -650.2% |
| Return on Equity | -38.2% | N/A | N/A | N/A | N/A | -38.4%+91.3pp | -31.1%-22.3pp | -48.3%-32.9pp |
| Return on Assets | -27.6%-4.2pp | N/A | -2.8%+5.8pp | -168.5%-157.6pp | -23.4%-16.7pp | -13.0%+33.4pp | -8.6%-3.6pp | -10.9%-1.8pp |
| Current Ratio | 0.38+0.2x | 0.11-0.1x | 0.150.0x | 0.060.0x | 0.19+0.1x | 0.23+0.1x | 0.110.0x | 0.08-0.2x |
| Debt-to-Equity | 0.39 | 1.54-0.4x | N/A | N/A | N/A | 1.95+0.2x | 2.62+1.8x | 3.42+3.4x |
| Asset Turnover | N/A | N/A | 0.040.0x | 0.040.0x | 0.030.0x | 0.010.0x | 0.020.0x | 0.020.0x |
Not reported in any period shown, so not listed: Gross Margin, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: The current ratio is below 1.0 (0.11), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Avalon Globocare Corp ALBT | FY2025 | N/A | -$18.3M | N/A | $3.6M | — |
| La Rosa Holdings Corp LRHC | FY2025 | $68.5M | -$30.5M | -44.6% | $1.4M | 4/100 |
| Wetouch Technology Inc WETH | FY2025 | $45.1M | $7.2M | 15.9% | $16.1M | 77/100 |
| New Concep GBR | FY2025 | $155K | -$46K | -29.7% | $4.0M | — |
| Fangdd Network Group Ltd. DUO | FY2025 | $50.7M | -$12.1M | -23.9% | $21.4M | 5/100 |
Where Avalon Globocare Corp Ranks
Frequently Asked Questions
Is Avalon Globocare Corp profitable?
No, Avalon Globocare Corp (ALBT) reported a net income of -$18.3M in fiscal year 2025.
What is Avalon Globocare Corp's EBITDA?
Avalon Globocare Corp (ALBT) had EBITDA of -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Avalon Globocare Corp's return on equity (ROE)?
Avalon Globocare Corp (ALBT) has a return on equity of -197.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Avalon Globocare Corp's operating cash flow?
Avalon Globocare Corp (ALBT) recorded an outflow of $4.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Avalon Globocare Corp's total assets?
Avalon Globocare Corp (ALBT) had $23.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Avalon Globocare Corp's current ratio?
Avalon Globocare Corp (ALBT) had a current ratio of 0.11 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Avalon Globocare Corp's debt-to-equity ratio?
Avalon Globocare Corp (ALBT) had a debt-to-equity ratio of 1.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Avalon Globocare Corp's return on assets (ROA)?
Avalon Globocare Corp (ALBT) had a return on assets of -78.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Avalon Globocare Corp's Piotroski F-Score?
Avalon Globocare Corp (ALBT) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Avalon Globocare Corp's earnings high quality?
Avalon Globocare Corp (ALBT) reported a net loss of $18.3M while operations used $4.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Avalon Globocare Corp cover its interest payments?
Avalon Globocare Corp (ALBT) reported an operating loss of $7.6M against $1.5M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.